Oral Corticosteroid Reduction Between Biologics Initiated and Non-Initiated Patients with Severe Asthma

PURPOSE: The oral corticosteroid (OCS)-sparing effect of several biologics (BIOs) has been shown in clinical trials. To date, no study has evaluated differences in OCS dose reduction between BIO-initiated and BIO-non-initiated patients in real-world clinical practice. We compared dose reductions in...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanaka, Akihiko, Takahashi, Mai, Fukui, Ayako, Arita, Yoshifumi, Fujiwara, Masakazu, Makita, Naoyuki, Tashiro, Naoki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438425/
https://www.ncbi.nlm.nih.gov/pubmed/37600852
http://dx.doi.org/10.2147/JAA.S411404

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438425/
https://www.ncbi.nlm.nih.gov/pubmed/37600852
http://dx.doi.org/10.2147/JAA.S411404

Ejemplares similares